Haematinics
[Haematinics ]
EPTIS factsheet 1615895 | Last revision 2026-09-24 | URL: https://www.eptis.bam.de/pts1615895 https://www.eptis.bam.de/pts1615895
| PT provider | ||||||||||||||||||||||||||||
| PT provider | Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust | |||||||||||||||||||||||||||
| Based in | United Kingdom | |||||||||||||||||||||||||||
| Language(s) | English | |||||||||||||||||||||||||||
| Remarks | Provides EQA coverage by means of predominantly endogenous levels of mainstream haematinic analytes which are required for the formation of blood cells in the process of hematopoiesis. The Scheme does cover the analytical working range, but does focus on the clinically important decision points. This Scheme includes Red Cell Folate. See separate schemes for Active B12/Holotranscobalamin and Erythropoietin. | |||||||||||||||||||||||||||
| Keywords | ||||||||||||||||||||||||||||
| Product groups |
Health care / medical devices
|
|||||||||||||||||||||||||||
| Testing fields |
Medical analysis
|
|||||||||||||||||||||||||||
| Technical details | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Aims of the PT scheme | ||||||||||||||||||||||||||||
| Target group of participants | Clinical Chemistry Public & Private Labs | |||||||||||||||||||||||||||
| Linked to specific legislation / standards | ISO/IEC 17043:2023 | |||||||||||||||||||||||||||
| Additional, subsidiary aims | Post market surveillance of testing methods | |||||||||||||||||||||||||||
| Number of participants | ||||||||||||||||||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043:2023 |
|||||||||||||||||||||||||||
| Operation is commissioned / requested by | ||||||||||||||||||||||||||||
| Fees and frequency | ||||||||||||||||||||||||||||
| Participation fee | Contact provider for current fee, which depends on location and extent of service required. | |||||||||||||||||||||||||||
| Regularly operated | Yes (Monthly (11 per year)) | |||||||||||||||||||||||||||
| Year of first operation | 2005 | |||||||||||||||||||||||||||
| Contact details of the PT provider | ||||||||||||||||||||||||||||
| Provider | Contact person | |||||||||||||||||||||||||||
|
Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Medical Centre P O Box 3909 B15 2SQ Birmingham United Kingdom Phone: +44 121 414 7300 Fax: Web: https://www.birminghamquality.org.uk https://www.birminghamquality.org.uk |
Birmingham Quality
Phone: +44 121 414 7300 Fax: Email: birminghamquality@uhb.nhs.uk birminghamquality@uhb.nhs.uk |
|||||||||||||||||||||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.